GSK-2879552
Product Specifications
CAS Number
1401966-69-5
Target
LSD1
Applications
Epigenetics
Molecular Formula
C23H28N2O2
Additionnal Information
GSK-2879552 is a selective and potent inhibitor of Lysine-specific demethylase 1 (LSD1, KDM1A), with the potential to treat Small cell lung cancer (SCLC) . It induces the expression of putative KDM1A target genes and demonstrates potent, predominantly cytostatic, antiproliferative activity in SCLC cell lines and tumor xenograft models.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6369919-01 0.1 mL
ANXA2 (Annexin A2, Annexin II, Annexin-2, Calpactin I Heavy Chain, Calpactin-1 Heavy Chain, Chromobindin-8, Lipocortin II, Placental Anticoagulant Protein IV, PAP-IV, Protein I, p36, ANX2, ANX2L4, CAL1H, LPC2D) (MaxLight 490)
Sign In for Pricing
View Details MBS6369919-02 5x 0.1 mL
ANXA2 (Annexin A2, Annexin II, Annexin-2, Calpactin I Heavy Chain, Calpactin-1 Heavy Chain, Chromobindin-8, Lipocortin II, Placental Anticoagulant Protein IV, PAP-IV, Protein I, p36, ANX2, ANX2L4, CAL1H, LPC2D) (MaxLight 490)
Sign In for Pricing
View Details 
148593 100 µg
TGIF2, Control Peptide (TGF-beta-induced Transcription Factor 2, TGFB-induced Factor 2, Homeobox Protein TGIF2, 5'-TG-3'-interacting Factor 2)
Sign In for Pricing
View Details